Follow
Benjamin Roin
Benjamin Roin
Assistant Professor, MIT Sloan School of Management
Verified email at mit.edu
Title
Cited by
Cited by
Year
Do firms underinvest in long-term research? Evidence from cancer clinical trials
E Budish, BN Roin, H Williams
Am. Econ. Rev. 105 (7), 2044-2085, 2013
3992013
Unpatentable drugs and the standards of patentability
BN Roin
Tex. L. Rev. 87, 503, 2008
3452008
Intellectual property versus prizes: Reframing the debate
BN Roin
The University of Chicago Law Review, 999-1078, 2014
1562014
The disclosure function of the patent system (or lack thereof)
BN Roin
Harvard Law Review, 2005
1382005
The case for tailoring patent awards based on time-to-market
BN Roin
UCLA Law Review 61 (3), 672-759, 2014
1222014
Medicines for the mind: policy-based “pull” incentives for creating breakthrough CNS drugs
DW Choi, R Armitage, LS Brady, T Coetzee, W Fisher, S Hyman, A Pande, ...
Neuron 84 (3), 554-563, 2014
742014
Patents and research investments: Assessing the empirical evidence
E Budish, BN Roin, H Williams
American Economic Review 106 (5), 183-187, 2016
652016
Do fixed patent terms distort innovation?: Evidence from cancer clinical trials
EB Budish, BN Roin, HL Williams
Evidence from Cancer Clinical Trials (September 5, 2013). Chicago Booth …, 2013
602013
Solving the problem of new uses
BN Roin
Available at SSRN 2337821, 2013
282013
Causal inference on patent protection
JM Kuhn, BN Roin, NC Thompson
Working Paper, 2016
72016
Drug patent length
BN Roin
Unpublished manuscript, Harvard Law School, 2010
72010
Solving the problem of new uses by creating incentives for private industry to repurpose off-patent drugs
BN Roin
Mich St L Rev, 2014
52014
DON'T MISS THESE GREAT FEBRUARY EVENTS!
J DiGiacinto, RS Langer, B Roin
University of Pennsylvania Law Review 165 (2), 2017
2017
Do firms underinvest in long-term research? Evidence from cancer clinical trials Online appendix
E Budish, BN Roin, H Williams
2015
Introduction, Regulatory Exclusivities and the Regulation of Generic Drugs and Biosimilars
BN Roin
FDA in the Twenty-First Century: The Challenges of Regulating Drugs and New …, 2015
2015
Online Appendix for: Patents and Research Investments: Assessing the Empirical Evidence
E Budish, BN Roin, H Williams
Measuring Patent Scope
JM Kuhn, BN Roin, NC Thompson
The system can't perform the operation now. Try again later.
Articles 1–17